VTRS — Viatris Inc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1792044 ·
Last close
$17.83
Market Cap
$20.48B
52W High
$18.25
52W Low
$9.15
ADV30
7,900,777
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 3,756,800,000 | 1,456,500,000 | 73,700,000 | -118,800,000 | 35,044,600,000 | 886,500,000 | 20,784,200,000 |
| Mar 2026 | 3,517,000,000 | 1,157,200,000 | -20,200,000 | 176,400,000 | 36,834,600,000 | 1,804,200,000 | 22,176,900,000 |
| Dec 2025 | 3,703,600,000 | 1,147,900,000 | -157,500,000 | -340,100,000 | 37,193,100,000 | 1,322,400,000 | 22,481,800,000 |
| Sep 2025 | 3,759,900,000 | 1,371,500,000 | 234,500,000 | -128,200,000 | 37,920,400,000 | 975,300,000 | 22,702,800,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,168,700,000
Investing CF
$-85,200,000
Financing CF
$-1,030,700,000
CapEx
$-512,900,000
Dividends Paid
$-557,500,000
Buybacks
$-325,100,000
EPS Diluted TTM
$-0.26
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-211,900,000
Inventory
$3,927,000,000
Receivables
$3,742,000,000
ST Investments
$596,000,000
EBIT TTM
$-339,400,000
Pretax Income TTM
$-815,300,000
Interest Exp TTM
$475,900,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$14,737,300,480
EBITDA
$4,292,499,968
Free Cash Flow
$2,677,337,600
Enterprise Value
$31,076,435,968
Total Cash
$1,510,499,968
Total Debt
$13,623,700,480
Shares Out
1,148,590,864
Trailing EPS
$-0.37
Book Value
$12.59
ROE
-2.8%
ROA
2.7%
Div Yield
2.91%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 14,299,900,000 | 253,500,000 | -3,514,900,000 | 37,193,100,000 | 22,481,800,000 | 14,711,300,000 | 2,315,900,000 |
| Dec 2024 | 14,739,300,000 | 710,300,000 | -634,200,000 | 41,500,900,000 | 22,865,400,000 | 18,635,500,000 | 2,302,900,000 |
| Dec 2023 | 15,426,900,000 | 1,563,400,000 | 54,700,000 | 47,685,500,000 | 27,218,100,000 | 20,467,400,000 | 2,900,000,000 |
| Dec 2022 | 16,262,700,000 | 1,655,700,000 | 2,078,600,000 | 50,022,200,000 | 28,949,900,000 | 21,072,300,000 | 2,999,000,000 |
TTM Snapshot
Revenues TTM
$15,025,600,000
NetIncome TTM
$-2,261,300,000
OpCashFlow TTM
$0
Assets (Latest)
$37,193,100,000
Forward EPS
$2.66
Max Pain — expiry 2026-10-16
max pain strike: $16.00 · spot: $17.88 · call oi: 12,830 · put oi: 3,821
Expected Move to 2026-10-16:
±$0.90
(5.03%) —
implied range
$16.98 –
$18.78
· ATM straddle on $18.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | $20.39B | $475.45 | — |
| GMAB | GENMAB A/S | $21.72B | $35.32 | — |
| INSM | INSMED Inc | $25.73B | $117.83 | — |
| ROIV | Roivant Sciences Ltd. | $25.86B | $35.80 | — |
| RPRX | Royalty Pharma plc | $25.92B | $58.21 | — |
News headlines (Yahoo Finance, 1h cache)
Is Viatris Stock Outperforming the S&P 500?
2026-09-24 10:57 · Yahoo
Viatris (VTRS) Wins Japan WAKIX Approval. Can it Build a Meaningful Specialty Business?
2026-09-21 00:03 · Yahoo
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
2026-09-02 13:15 · Yahoo
Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris
2026-08-28 09:15 · Yahoo
Viatris' China Policy Concerns Overstated, UBS Says
2026-08-19 16:16 · Yahoo
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
2026-08-13 23:03 · Yahoo
Viatris sues Novo Nordisk over generic Wegovy patent dispute
2026-09-25 19:53 · Yahoo
3 US Stocks That Could Gain If Buyers Shift Away From India
2026-09-19 17:14 · Yahoo
Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome
2026-09-16 10:59 · Yahoo
3 Healthcare Stocks That Fall Short
2026-09-14 15:23 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.